Heidi Henson CPA — Chief Financial Officer and Secretary at Kura Oncology

Ms. Heidi Henson, CPA, has been the Chief Financial Officer and Secretary at Kura Oncology, Inc. since March 2015. Ms. Henson has been the Chief Financial Officer of Araxes Pharma, LLC since July 2012. Ms.Henson has served as Chief Financial Officer and Secretary of Wellspring Biosciences LLC since July 2012. She served as a Director of Finance at Intellikine, Inc. Shehas served as Secretary of Araxes Pharma, LLC. since July 2012. Ms. Henson joined Intellikine, Inc. in 2007. From 2007 to March 2012, Ms. Henson served as the Vice President of Finance at Intellikine, Inc. She served as a Director of Finance at Anadys Pharmaceuticals Inc. from January 2003 to September 2004 and served as Principal Accounting Officer until September 2004. Ms. Henson has served as an independent financial consultant for the past several years assisting with various start-up activities for early stage companies, SEC reporting and Sarbanes-Oxley implementation and compliance. She held a number of management positions with Fair Isaac & Co., Inc., a developer of predictive software solutions. Ms. Henson began her career in auditing with PricewaterhouseCoopers where she served both public and private companies. She served as Anadys Pharmaceuticals Inc.'s Controller from November 2002 to January 2003. From 1996 to 2002, Ms. Henson worked at Fair Isaac Corporation, a publicly traded company which was formerly HNC Software Inc., where she held a variety of positions includes Director, Internal Audit; Controller for the eHNC division; Assistant Corporate Controller; Financial Reporting Manager and Senior Financial Analyst. From March 1996 to August 1996, She served as Financial Analyst for Alaris Medical Systems, Inc., which was formerly IVAC Medical Systems, Inc., and from 1992 to 1996 she was an auditor with PricewaterhouseCoopers LLP. Ms. Henson received her Bachelor of Accountancy from the University of San Diego and is a Certified Public Accountant.